Clinical Trial Update: Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis [Phase 2]

View source ↗

Summary

This update summarizes a Phase 2 dose-finding trial of SAR442168 for relapsing multiple sclerosis, with results posted after study completion in March 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• SAR442168

Snippet

Sponsor: Sanofi | Conditions: Relapsing Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2023-03-08